Lack of Synergy for Glucagon and GLP-1 on Acute Beta-Cell Function and Insulin Sensitivity in Mice

被引：0
|
作者：
Pacini, Giovanni
Ahren, Bo
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1749-P
引用
收藏
页码：A452 / A452
页数：1
相关论文
共 50 条
  • [41] Impact of endogenous and exogenous GLP-1 on glucagon secretion in type 1 diabetic patients with and without residual beta -cell function
    Kielgast, U.
    Madsbad, S.
    Holst, J.
    [J]. DIABETOLOGIA, 2009, 52 : S58 - S59
  • [42] GLP-1 agonist liraglutide improves insulin sensitivity
    Di Lellis, Maddalena Angela
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (03) : 172 - 172
  • [43] Acute Metabolic Effects of MEDI0382, a GLP-1/Glucagon Dual Agonist, in Wild Type and GLP-1 Receptor Knockout (GLP-1RKO) Mice
    Will, Sarah E.
    Naylor, Jacqueline
    Rossi, Alessandra
    Hornigold, David
    Oldham, Stephanie
    Trevaskis, James
    Konkar, Anish
    [J]. DIABETES, 2016, 65 : A35 - A35
  • [44] Tirzepatide, a dual GIP and GLP-1 receptor agonist, improves markers of beta cell function and insulin sensitivity in type 2 diabetes patients
    Thomas, M. K.
    Nikooienejad, A.
    Bray, R.
    Cui, X.
    Wilson, J.
    Duffin, K.
    Milicevic, Z.
    Haupt, A.
    Robins, D. A.
    [J]. DIABETOLOGIA, 2019, 62 : S354 - S354
  • [45] Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice
    Ahrén, B
    Pacini, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (06): : E996 - E1004
  • [46] Increased insulin sensitivity and diminished pancreatic beta-cell function in DNA repair deficient Ercc1d/- mice
    Guevara, Ana P. Huerta
    McGowan, Sara J.
    Kazantzis, Melissa
    Stallons, Tania Rozgaja
    Sano, Tokio
    Mulder, Niels L.
    Jurdzinski, Angelika
    van Dijk, Theo H.
    Eggen, Bart J. L.
    Jonker, Johan W.
    Niedernhofer, Laura J.
    Kruit, Janine K.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 117
  • [47] From classical dualistic antagonism to hormone synergy: potential of overlapping action of glucagon, insulin and GLP-1 for the treatment of diabesity
    Kistkins, Svjatoslavs
    Moser, Othmar
    Ankudovics, Vitalijs
    Bliznuks, Dmitrijs
    Mihailovs, Timurs
    Lobanovs, Sergejs
    Sourij, Harald
    Pfeiffer, Andreas F. H.
    Pirags, Valdis
    [J]. ENDOCRINE CONNECTIONS, 2024, 13 (05)
  • [48] Discovery of Insulin/GLP-1/Glucagon Triagonists for the Treatment of Diabetes and Obesity
    Huang, Chunhui
    Palani, Anandan
    Yang, Zhiqiang
    Deng, Qiaolin
    Reddy, Vijay
    Nargund, Ravi P.
    Lin, Songnian
    Altezza, Simona
    Bianchi, Elisabetta
    Orvieto, Federica
    Carrington, Paul
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2022, : 1255 - 1261
  • [49] Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice
    Wei, Tianjiao
    Cui, Xiaona
    Jiang, Yafei
    Wang, Kangli
    Wang, Dandan
    Li, Fei
    Lin, Xiafang
    Gu, Liangbiao
    Yang, Kun
    Yang, Jin
    Hong, Tianpei
    Wei, Rui
    [J]. DIABETES, 2023, 72 (05) : 599 - 610
  • [50] GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes
    Halden, Thea A. S.
    Egeland, Erlend J.
    Asberg, Anders
    Hartmann, Anders
    Midtvedt, Karsten
    Khiabani, Hassan Z.
    Holst, Jens J.
    Knop, Filip K.
    Hornum, Mads
    Feldt-Rasmussen, Bo
    Jenssen, Trond
    [J]. DIABETES CARE, 2016, 39 (04) : 617 - 624
12345